About PSC Biotech Corporation
PSC Biotech Corporation news and updates
PSC Biotech partners with Helicaseventure
Biotech and pharma innovators partner with Helicaseventure to develop new protein-based drugs, including those that may be impossible to make with other technologies.
Jan 1, 2021 | helicaseventure.comCoalition for Epidemic Preparedness Innovations partners with Biotech
CEPI will partner with UK-based DIOSynVax – a Biotech spinout of the University of Cambridge that specialises in the development of broadly protective, multi-virus vaccine antigen payloads (VAPs) – to develop a vaccine candidate based upon intelligent computational design that could provide protection against both existing and future variants of SARS-CoV-2 – the virus which causes COVID-19 disease – as well as other major sub-genera of Betacoronaviruses including those which cause SARS and MERS.
Jan 1, 2022 | cepi.netBiotech partners with Actionable Insights
Biotech and pharma innovators partner with Actionable Insights to create the next generation of protein-based drugs, including Bionic™ Proteins containing nonstandard amino acids, and other novel drug designs that may be impossible to make with other technologies.
Jan 1, 2022 | globenewswire.comAegasislabs partners with Biotech
Aegasis Labs partnered up with Biotech startup, Novai, to build the a platform for them.
Jan 1, 2022 | aegasislabs.comBiotech hires Nicholas Florko as correspondent
STAT Washington correspondent Nicholas Florko joins Biotech to discuss the FDA’s decision to ban the sale of Juul Labs vaping products and a proposal to reduce the amount of nicotine in cigarettes.
Jan 1, 2022 | statnews.comBiotech hires Allison DeAngelis
Its colleague Allison DeAngelis joins Biotech to explain how the prolonged downturn for biotech stocks is stoking anxiety among venture capitalists.
Jan 1, 2022 | statnews.comBiotech partners with Pharmaceutical Tech
Biotech and pharma innovators partner with Pharmaceutical Tech to create the next generation of protein-based drugs, including Bionic Proteins™ containing nonstandard amino acids, and other novel drug designs that may be impossible to make with other technologies.
Jan 1, 2022 | pharmaceutical-tech.comBiotech hires Rachel Cohrs as Washington correspondent
Rachel Cohrs, STAT’s Washington correspondent, joins Biotech to explain how congressional Democrats are on the verge of a coup in drug pricing — and what could still stand in their way.
Jan 1, 2022 | statnews.comBiotech hires Katie Palmer
Its colleague Katie Palmer joins Biotech to explain a burgeoning trend in pharmaceutical advertising that has health policy experts alarmed.
Sep 14, 2022 | statnews.comBoutiquevc invests into Biotech in $2.6M
Biotech and medical AI innovator Surge announced a $2.6 million round co-led by HCVC, a global early-stage fund dedicated to high-potential technology startups, and Boutique Venture Partners, a leading fund based in the Silicon Valley.
Sep 23, 2022 | prnewswire.comBiotech hires Sarah Owermohle
Its colleague Sarah Owermohle joins Biotech to discuss how pandemic shutdowns, Covid-19 vaccines, and the prospect of arresting Anthony Fauci have become campaign rallying cries in midterm elections.
Oct 26, 2022 | statnews.comBiotech launches 6 new languages to the suite of PSC Software applications
Biotech has added 6 new languages to the suite of PSC Software ® applications.
Nov 14, 2022 | biotech.com